Clenbuterol was initially developed as a bronchodilator for treating respiratory conditions. As a beta-2 adrenergic agonist, it influences the body’s beta-2 adrenergic receptors, yielding effects
Ibutamoren, also known as MK-677, non-peptide agonist of the growth hormone secretagogue receptor (GHSR) that has shown significant potential in enhancing sleep quality.